NCT07575841Not yet recruiting
Pulmonary Rehabilitation Frequency in COPD Patients
Comparative Efficacy of a Supervised Pulmonary Rehabilitation Program Performed 3 Days/Week Versus 1 Day/Week in Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
Chronic obstructive pulmonary disease (COPD) is a common condition that can cause breathlessness and reduced physical capacity. Pulmonary rehabilitation (PR) is an effective treatment, but traditional programs often require patients to attend sessions several times per week, which may limit participation. This study aims to compare the effectiveness of two supervised pulmonary rehabilitation programs: one performed 3 days per week and another performed 1 day per week, both over an 8-week period and including additional home-based exercises. The main objective is to determine whether the lower-frequency program is not inferior to the higher-frequency program in improving functional capacity, measured by the six-minute walk test. Secondary outcomes include dyspnea, quality of life, muscle strength, physical activity, adherence, exacerbations, and safety. The results of this study may help optimize pulmonary rehabilitation programs and improve accessibility for patients with COPD.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 158 (estimated)
- First submitted
- 4 May 2026
- Start date
- 1 Jan 2027
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- Hospital Universitario Fundación Alcorcón
- Diseases
- COPD
- NCT number
- NCT07575841
What you commit to
- Study type: Interventional
- Planned participants: 158
- From 1 Jan 2027 to the primary completion date, 31 Jan 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unstable cardiac or musculoskeletal comorbidity contraindicating or limiting exercise
- Moderate to severe cognitive impairment or inability to understand instructions
Other
- Recent participation (\<6 months) in a complete pulmonary rehabilitation programme
- Inability to attend the centre 1-3 days/week according to group allocation
- Current participation in any structured pulmonary rehabilitation programme or supervised rehabilitation intervention in another centre.
- Active oncological treatment
Criteria the registry did not label
- IInclusion criteria
- Diagnosis of COPD confirmed by spirometry (FEV₁/FVC \<0.70)
- Modified Medical Research Council (mMRC) dyspnoea scale ≥2
- Ability to actively participate and perform physical exercise
- Signed informed consent
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.